Title: 2015 ACVIM Forum Research Abstract Program Document date: 2015_5_27
ID: 3pnuj5ru_420
Snippet: The decrease in cPLI concentrations would suggest an attenuation of acinar cell damage but evaluation of efficacy requires further controlled studies. Despite marked individual decreases, no significant anti-inflammatory or anti-fibrotic properties were identified. Oral CM therapy at doses up to 24 mg/kg/d for up to 31 days was found to be safe in dogs with suspected chronic pancreatitis, with only mild adverse effects reported. The purpose of th.....
Document: The decrease in cPLI concentrations would suggest an attenuation of acinar cell damage but evaluation of efficacy requires further controlled studies. Despite marked individual decreases, no significant anti-inflammatory or anti-fibrotic properties were identified. Oral CM therapy at doses up to 24 mg/kg/d for up to 31 days was found to be safe in dogs with suspected chronic pancreatitis, with only mild adverse effects reported. The purpose of this study was to investigate b-hydroxybutyrate (BOHB) concentrations in dogs with acute pancreatitis (AP) and without diabetes mellitus.
Search related documents:
Co phrase search for related documents- chronic pancreatitis and cpli concentration: 1
- chronic pancreatitis and diabetes mellitus: 1, 2
- chronic pancreatitis and study purpose: 1, 2
- cm therapy and study purpose: 1, 2
- control study and diabetes mellitus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57
- control study and efficacy evaluation: 1, 2, 3, 4, 5
- control study and mild adverse effect: 1
- control study and study purpose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- cpli concentration and study purpose: 1, 2
- diabetes mellitus and study purpose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52
- efficacy evaluation and study purpose: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date